{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:45:20Z","timestamp":1771512320175,"version":"3.50.1"},"reference-count":50,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2009,10,29]],"date-time":"2009-10-29T00:00:00Z","timestamp":1256774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[2009,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To assess the expression of B lymphocyte stimulator (BLyS) in patients with pediatric systemic lupus erythematosus (SLE) or juvenile idiopathic arthritis (JIA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Blood samples collected from patients with pediatric SLE (n = 56) and patients with JIA (n = 54) at the beginning and end of a 6\u2010month interval were analyzed for plasma BLyS protein levels by enzyme\u2010linked immunosorbent assay and for blood leukocyte full\u2010length BLyS and \u0394BLyS messenger RNA (mRNA) levels by quantitative real\u2010time polymerase chain reaction (normalized to 18S expression). Healthy siblings (n = 34) of these patients served as controls.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In pediatric SLE, plasma BLyS protein and blood leukocyte BLyS mRNA levels were each significantly elevated, and plasma BLyS protein levels, but not blood leukocyte BLyS mRNA levels, were correlated with disease activity. In contrast, plasma BLyS protein levels were normal in JIA despite blood leukocyte BLyS mRNA levels being elevated to degrees similar to those in pediatric SLE. Among JIA patients, neither BLyS parameter was correlated with disease activity. In both pediatric SLE and JIA, the BLyS expression profiles remained stable at 6 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our findings indicate that, as previously noted in adult SLE, plasma BLyS protein and blood leukocyte BLyS mRNA levels are elevated in pediatric SLE. The correlation of plasma BLyS protein levels with disease activity points to BLyS as a candidate therapeutic target in pediatric SLE. Contrary to previous observations in adults with rheumatoid arthritis, plasma BLyS protein levels are normal in JIA despite elevated blood leukocyte BLyS mRNA levels. The absence of correlation between either of the BLyS parameters and disease activity in JIA calls for circumspection prior to assigning BLyS as a candidate therapeutic target in this disorder.<\/jats:p><\/jats:sec>","DOI":"10.1002\/art.24902","type":"journal-article","created":{"date-parts":[[2009,10,29]],"date-time":"2009-10-29T21:16:37Z","timestamp":1256850997000},"page":"3400-3409","source":"Crossref","is-referenced-by-count":25,"title":["B lymphocyte stimulator expression in pediatric systemic lupus erythematosus and juvenile idiopathic arthritis patients"],"prefix":"10.1002","volume":"60","author":[{"given":"Sandy D.","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Reiff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai\u2010Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thi\u2010Sau","family":"Migone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher D.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Marzan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bracha","family":"Shaham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wee Choo","family":"Phei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Garza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bram","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Stohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,10,29]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.4.1295"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.10.1639"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032534"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5425.260"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.189.11.1747"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M306852200"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.1.198"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021343"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-02-0564"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.175.1.319"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/35010115"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(02)00425-9"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/89782"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(01)00183-2"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.1.6"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.10860"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/ar1855"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.23678"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.23047"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1186\/ar2506"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.23178"},{"key":"e_1_2_7_24_2","first-page":"83","article-title":"Evaluation of the 1982 ARA lupus criteria data set in pediatric patients","volume":"12","author":"Ferraz MB","year":"1994","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_7_25_2","first-page":"1991","article-title":"Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997","volume":"25","author":"Petty RE","year":"1998","journal-title":"J Rheumatol"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20820"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350606"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.11111"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.079954"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21650"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.079418"},{"key":"e_1_2_7_32_2","first-page":"1256","article-title":"Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis","volume":"35","author":"Bosello S","year":"2008","journal-title":"J Rheumatol"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(02)00015-7"},{"key":"e_1_2_7_34_2","first-page":"423","volume-title":"Treatment of the rheumatic diseases: companion to Kelley's textbook of rheumatology","author":"Shaham B","year":"2001"},{"key":"e_1_2_7_35_2","first-page":"233","article-title":"Age\u2010related changes in BAFF and APRIL profiles and upregulation of BAFF and APRIL expression in patients with primary antibody deficiency","volume":"21","author":"Jin R","year":"2008","journal-title":"Int J Mol Med"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2008.06.001"},{"key":"e_1_2_7_37_2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1160\/TH08-08-0543","article-title":"Elevation of B cell\u2010activating factor belonging to the tumour necrosis factor family (BAFF) in haemophilia A patients with inhibitor","volume":"101","author":"Takeda T","year":"2009","journal-title":"Thromb Haemost"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.24699"},{"key":"e_1_2_7_39_2","first-page":"S710","article-title":"Belimumab (BmAb), a fully human monoclonal antibody to B\u2010lymphocyte stimulator (BLyS), combined with standard of care therapy reduces the signs and symptoms of rheumatoid arthritis in a heterogeneous subject population","volume":"52","author":"McKay J","year":"2005","journal-title":"Arthritis Rheum"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gene.6363923"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1186\/ar1884"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.7938"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gene.6363770"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1600"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1601"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-007-9094-y"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-005-5637-2"},{"key":"e_1_2_7_48_2","first-page":"S20","article-title":"Finally found: human BAFF\u2010R deficiency causes hypogammaglobulinemia","volume":"115","author":"Warnatz K","year":"2005","journal-title":"Clin Immunol"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.45.6.502"},{"key":"e_1_2_7_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni829"},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1007676"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.24902","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.24902","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T05:41:58Z","timestamp":1697002918000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.24902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,29]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["10.1002\/art.24902"],"URL":"https:\/\/doi.org\/10.1002\/art.24902","archive":["Portico"],"relation":{},"ISSN":["0004-3591","1529-0131"],"issn-type":[{"value":"0004-3591","type":"print"},{"value":"1529-0131","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,29]]}}}